Answers are grounded in this paper and cite their sources.
Many researchers have reported immunohistochemistry of breast pathology studied using image-analysis software.Aims: This study was to confirm the availability of digital image analysis (DIA) for breast pathology using immunohistochemistry for a myoepithelial marker with an antibody cocktail targeting CK14/p63 to differentiate ductal carcinoma in situ (DCIS) from invasive ductal cancer (IDC). Methods and Material:We collected 139 consecutive core needle biopsy (CNB) specimens diagnosed as "malignant".All 139 CNB specimens were stained with a cocktail of antibodies targeting CK14/p63.All stained sections were photographed using data be scanned by a whole-slide imaging system.The images were analyzed using software to clarify the proportions of tumor cells that were positive or negative for the marker.The cutoff value for CK14/p63 (negative or positive) was determined using receiver operating characteristic (ROC) analysis.Results: The cutoff value for CK14/p63 was 3.17%, and a significant difference was found between DCIS and IDC (P < .0001).In DIA Dx, the sensitivity, specificity, positive predictive value for IDC, and negative predictive value for IDC were 76.9%, 83.3%, 93.9%, and 34.9%, respectively (P < .0001).Conclusion: DIA of immunostaining for CK14/p63 of breast cancer specimens is useful for distinguishing between DCIS and IDC.
No takes yet. Share an insight, caveat, or question.
Ichiro Maeda (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: